We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

103 hedge funds and large institutions have $259M invested in GenMark Diagnostics, Inc in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 29 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 29

3% less funds holding

Funds holding: 106 → 103 (-3)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

35% less capital invested

Capital invested by funds: $400M → $259M (-$142M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $59K

Holders
103
Holders Change
-3
Holders Change %
-2.83%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
34
Reduced
29
Closed
15
Calls
–
Puts
$59K
Net Calls
-$59K
Net Calls Change
-$59K

Top Buyers

Rank Fund Capital Flow
1
CCM
Cadian Capital Management
New York
+$6.13M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$3.63M
3
BG
Bellevue Group
Switzerland
+$3.44M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.38M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$3.31M

Top Sellers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
-$25.7M
2
JP Morgan Chase
JP Morgan Chase
New York
-$3.32M
3
Millennium Management
Millennium Management
New York
-$3.06M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$2.67M
5
Morgan Stanley
Morgan Stanley
New York
-$2.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$1M -$2.56M -491,777 -70%
Federated Hermes
27
Federated Hermes
Pennsylvania
$972K – – –
Deutsche Bank
28
Deutsche Bank
Germany
$949K -$895K -171,852 -47%
KCM
29
Kennedy Capital Management
Missouri
$937K -$2.31K -444 -0.2%
Two Sigma Investments
30
Two Sigma Investments
New York
$877K +$28.7K +5,507 +3%
BCM
31
Bridgeway Capital Management
Texas
$874K – – –
TD Asset Management
32
TD Asset Management
Ontario, Canada
$767K -$166K -31,800 -17%
TCIM
33
TIAA CREF Investment Management
New York
$752K -$6.19K -1,189 -0.8%
SSA
34
Schonfeld Strategic Advisors
New York
$729K -$1.18M -226,000 -60%
MCM
35
Moore Capital Management
New York
$729K +$781K +150,000 New
Two Sigma Advisers
36
Two Sigma Advisers
New York
$702K -$34.9K -6,700 -4%
GIP
37
Granite Investment Partners
California
$668K +$133K +25,592 +23%
WMSA
38
Weiss Multi-Strategy Advisers
New York
$634K – – –
Citadel Advisors
39
Citadel Advisors
Florida
$607K +$548K +105,198 +531%
TA
40
Teachers Advisors
New York
$603K -$26.4K -5,078 -4%
Ameriprise
41
Ameriprise
Minnesota
$550K +$589K +113,175 New
Goldman Sachs
42
Goldman Sachs
New York
$469K +$96.4K +18,514 +24%
Swiss National Bank
43
Swiss National Bank
Switzerland
$455K +$24.5K +4,700 +5%
William Blair & Company
44
William Blair & Company
Illinois
$453K – – –
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$447K +$241K +46,236 +101%
OAM
46
Oxford Asset Management
United Kingdom
$403K +$432K +82,926 New
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$386K – – –
RA
48
Royce & Associates
New York
$370K -$65.6K -12,600 -14%
DCM
49
Donaldson Capital Management
Indiana
$306K -$104K -20,000 -24%
UBS AM
50
UBS AM
Illinois
$304K – – –
1
2
3 4 5

GNMK Hedge Fund Activity: Q4 2018 in Review

103 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2018, worth a combined $259M — down 35% from $400M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of GNMK and 12 opened new positions — a net loss of 3 holders — while 29 trimmed existing stakes and 34 added.

The largest buyer was Cadian Capital Management, adding an estimated $6.13M. The largest seller was Putnam Investments, exiting entirely with an estimated $25.7M sold.

  • 103 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2018, down from 106 in Q3 2018.
  • Funds reported $259M of GenMark Diagnostics, Inc stock for Q4 2018, down 35% quarter-over-quarter.
  • 12 funds opened new GenMark Diagnostics, Inc positions in Q4 2018 and 15 closed out, a net change of -3 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q4 2018 was Cadian Capital Management, an estimated $6.13M added.
  • The largest GenMark Diagnostics, Inc seller in Q4 2018 was Putnam Investments, an estimated $25.7M sold.

Based on aggregated 13F filings for Q4 2018.